Tailored P2Y 12 inhibitor treatment in patients undergoing non-urgent PCI —the POPular Risk Score study
ConclusionSelective intensification of P2Y12 inhibitor treatment after non-urgent PCI based on the POPular Risk Score is associated with a reduction in thrombotic events without an increase in bleeding events.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Angioplasty | Bleeding | Clopidogrel | Coronary Angioplasty | Drugs & Pharmacology | Heart Attack | Percutaneous Coronary Intervention | Plavix | Stroke | Study | Thrombosis